You have 9 free searches left this month | for more free features.

safety analysis

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Novel Algorithm System for Polypharmacy Patient Medication

Completed
  • Polypharmacy Patients
  • Multi-drug analysis of polypharmacy treatment
  • Jerusalem, Israel
    Hadassah Ein Kerem
Oct 18, 2022

Anesthesia, General, Neuromuscular Blockade Trial in Seoul (Sugammadex Injection 2mg/kg, Sugammadex Injection 4mg/kg, Sugammadex

Completed
  • Anesthesia, General
  • Neuromuscular Blockade
  • Sugammadex Injection 2mg/kg
  • +3 more
  • Seoul, Jongro Gu, Korea, Republic of
    SNUH
Oct 20, 2022

Ceftazidime-avibactam in Management of Gram Negative Infections

Completed
  • Gram Negative Infections
  • Bhandup West, India
  • +7 more
Jan 20, 2023

Meibomian Gland Dysfunction, Blepharitis Trial in Alicante (Study group, Control group)

Recruiting
  • Meibomian Gland Dysfunction
  • Blepharitis
  • Study group
  • Control group
  • Alicante, Spain
    Alicante Vissum Miranza
Oct 17, 2022

Progression Free Survival(PFS) Trial (Toposide capsules combined with anrotinib and Emvolizumab group)

Not yet recruiting
  • Progression Free Survival(PFS)
  • Toposide capsules combined with anrotinib and Emvolizumab group
  • (no location specified)
Jan 13, 2023

MS Had Greater Than 60 Infusions of Natalizumab

Active, not recruiting
  • Multiple Sclerosis
  • Latham, New York
    Multiple Sclerosis Center of Northeastern New York, P.C.
Mar 23, 2022

Multaq® for Safety in Atrial Fibrillation

Completed
  • Atrial Fibrillation
  • Chilly-Mazarin, France
    Sanofi-Aventis, France
Apr 20, 2022

Polyethylene Glycols, Children, Only Trial (PEG 3350)

Not yet recruiting
  • Polyethylene Glycols
  • Children, Only
  • PEG 3350
  • (no location specified)
Jul 28, 2022

Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals

Recruiting
  • Hematologic Neoplasms
  • COVID-19 Vaccines
  • S-binding IgG, RBD-binding IgG and N-binding IgG immunoassays and SARS-CoV-2 serum neutralization assay, quantitative serum immunoglobulin tests
  • +2 more
  • Vilnius, Lithuania
    Vilnius University Hospital Santaros Klinikos
Dec 27, 2021

Women Who Underwent Primary and Secondary Breast Augmentation

Recruiting
  • Breast Implant; Complications
  • +2 more
  • Silimed® Textured Silicone Gel-Filled Breast Implant
  • Silimed® Polyurethane Foam Covered Silicone Gel-Filled Breast Implant
  • Niterói, Rio De Janeiro, Brazil
    Perfektua Serviços Médicos Ltda
Jan 11, 2023

Safety of RuiXin-CoronaryAI for Diagnosis of Coronary Artery

Recruiting
  • Coronary Artery Disease
  • +3 more
  • RuiXin-CoronaryAI software
  • Beijing, Beijing, China
  • +2 more
Sep 19, 2022

Climate in the Hybrid Angiography Suite

Completed
  • Healthy Volunteers
  • Aortic Aneurysm, Abdominal
  • Assessment of radiation safety climate
  • +3 more
  • Ghent, Oost Vlaanderen, Belgium
  • +4 more
Nov 24, 2021

Healthy Adult Volunteers Trial in Taipei City (ChAdOx1-nCov-19 (Astra-Zeneca), SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine)

Completed
  • Healthy Adult Volunteers
  • ChAdOx1-nCov-19 (Astra-Zeneca)
  • SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine
  • Taipei City, X, Taiwan
    National Taiwan University Hospital
Oct 16, 2022

Chadox1 Ncov-19 Vaccine: Rapid Systematic Review and Meta

Active, not recruiting
  • ChAdOx1 nCoV-19 Vaccine
  • ChAdOx1 nCoV-19 vaccine
  • Assiut, Egypt
    Aliae AR Mohamed-Hussein
Sep 18, 2021

Outpatient Cervical Ripening

Completed
  • Pregnancy
    • Greenville, South Carolina
      Prisma Health
    May 17, 2022

    Desflurane in Automated Gas Control Mode

    Completed
    • Safety Issues
      • Malatya, Turkey
        Inonu Univercity
      Aug 24, 2021

      Anesthesia, General, Neuromuscular Blockade Trial in Seoul (Sugammadex Injection 2mg/kg, Sugammadex Injection 4mg/kg, Sugammadex

      Completed
      • Anesthesia, General
      • Neuromuscular Blockade
      • Sugammadex Injection 2mg/kg
      • +3 more
      • Seoul, Jongro Gu, Korea, Republic of
        SNUH
      Feb 8, 2022

      VQI DELTA Paclitaxel Device Safety Analysis

      Completed
      • Peripheral Vascular Disease
      • Burlington, Massachusetts
        Lahey Clinic, Inc.
      Oct 13, 2020

      Luminal B/HER2-negative Breast Cancer Trial in Hangzhou (Dalpiciclib combined with aromatase inhibitors,

      Recruiting
      • Luminal B/HER2-negative Breast Cancer
      • Dalpiciclib combined with aromatase inhibitors
      • anthracycline-cyclophosphamide followed by taxane
      • Hangzhou, China
        2nd Affiliated Hospital, School of Medicine, Zhejiang University
      Nov 30, 2022

      Breast Cancer, Cardiac Toxicity Trial in Rochester (biological, drug, genetic, other, procedure)

      Completed
      • Breast Cancer
      • Cardiac Toxicity
      • trastuzumab
      • +11 more
      • Rochester, Minnesota
        Mayo Clinic Cancer Research Consortium
      Jul 12, 2022

      Asymptomatic Hyperuricemia Trial in Bengbu (SIBP-R002, Dexamethasone or Methyl prednisolone, Diphenhydramine)

      Recruiting
      • Asymptomatic Hyperuricemia
      • Bengbu, Anhui, China
        The first affiliated hospital of Bengbu medical college
      Apr 6, 2022

      Pivotal, Single-arm Clinical Trialto Assess Efficacy and Safety

      Completed
      • Stable Angina
      • +2 more
      • Collecting invasive FFR measurements.
      • Hadera, Central District, Israel
      • +2 more
      Apr 5, 2022

      Thoracic Aorta, Thoracic Aorta Aneurysm, Thoracic Aorta Abnormality Trial in Milano, Brescia, Barcelona (thoracic endovascular

      Recruiting
      • Thoracic Aorta
      • +2 more
      • thoracic endovascular repair
      • Milano, Lombardia, Italy
      • +2 more
      Sep 18, 2021

      Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Jacksonville (drug,

      Active, not recruiting
      • Metastatic Melanoma
      • +3 more
      • Jacksonville, Florida
        Mayo Clinic in Florida
      Jan 3, 2023

      Heart Failure Trial in Cincinnati (Ruboxistaurin)

      Withdrawn
      • Heart Failure
      • Cincinnati, Ohio
        The Lindner Center for Research and Education at The Christ Hosp
      Jun 1, 2022